New genetic mutations found for non-Hodgkin lymphoma
July 28, 2011 By Sara Hammond, Arizona Cancer Center in CancerScientists at the BC Cancer Agency in British Columbia, Canada and their U.S. collaborators have identified a number of new genetic mutations involved in non-Hodgkin lymphoma, or NHL.
This massive cancer-sequencing study, published online in the journal Nature, will open a floodgate for researchers around the world to explore the significant number of newly discovered gene mutations and their role in the growth and development of lymphoma cells.
The work was performed at the BC Cancer Agency Genome Sciences Centre, which has received major support from several governmental and private sources, including the U.S. National Institutes of Health in Bethesda, Md.
In an extensive undertaking, researchers sequenced the entire genome of lymphoma cancer cells from 14 NHL patient samples and the "active" genes from 117 NHL patients to search for genetic mutations specific to cancer cells.
Tumor samples were collected from British Columbia scientists as well as their U.S. collaborators, including the Arizona Lymphoma Repository housed at the University of Arizona's College of Medicine under the direction of Dr. Lisa Rimsza, a professor of pathology and Arizona Cancer Center member.
The magnitude of data revealed 109 genes with recurring mutations, from which 26 have been identified as contributors to NHL based on their mutation patterns. More than two-thirds of mutated genes had never been linked to lymphoma prior to this study.
Understanding tumors' genetic signatures "tells us what makes the tumors tick and what might be their vulnerable spots to aim for with treatment. This information should provide better diagnoses, more accurate prognostic information and help to identify unique targets of therapy for each tumor type, therefore advancing personalized medicine for our patients," Rimsza said.
"Based on the patterns of mutation in these 26 genes, we can see that these mutations enable tumor cells to grow and expand in non-Hodgkin lymphoma patients," said Ryan Morin, the study's lead author. "The mutated genes we've discovered, most of which were previously unknown to lymphoma or other cancers, should enable us to design new tests that allow us to recognize subtypes of lymphoma and may help us predict how each variation of this disease will react to different treatments."
Non-Hodgkin lymphoma is the fifth most common form of cancer in Canada, and the fourth most common cause of cancer in the U.S.
"This new abundance of genetic information is thrilling. Researchers and clinicians can now collaborate to eventually create new drugs, or identify existing drugs, that inhibit these mutated genes directly and prevent the growth of non-Hodgkin lymphoma," said Dr. Joseph Connors, a medical oncologist and distinguished scientist at the BC Cancer Agency and a clinical professor of medical oncology at the University of British Columbia.
The pattern of mutation observed in some of these genes is indicative of new tumor suppressors and oncogenes, the latter of which may be ideal targets for existing therapies.
Specifically, one of the novel lymphoma-related genes discovered in this study, MLL2, is mutated in 89 percent of Follicular lymphoma patients, suggesting it is the most commonly mutated gene in NHL. Mutation of MLL2, which appears to be a tumor suppressor, is suspected to provide cancer cells with the ability to grow rapidly in-spite of the body's regulatory mechanisms.
A second novel gene discovery, MEF2B, bears a so-called "hot spot" mutation pattern reminiscent of other known cancer genes.
Provided by
University of Arizona
-
Scientists identify possible gene target for treating a form of lymphoma
Dec 22, 2010 |
not rated yet |
0
-
New mutation linked to non-Hodgkin's lymphoma
Nov 01, 2010 |
not rated yet |
0
-
Sniffing out lymphoma by turning dogs into humans
Apr 06, 2011 |
not rated yet |
0
-
Novel test identifies leukemia patients likely to respond to new therapy
Feb 20, 2007 |
not rated yet |
0
-
Connecting cancer genes
May 15, 2008 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Nonsmoking lung cancer survivor encourages others to consider risk
Carol Seibert had an upper respiratory infection she just couldnt seem to shake. The timing of her illness was awful, as she had just returned from a trip to Florida for her youngest sons surgery and was preparing ...
Cancer
2 hours ago |
not rated yet |
0
Brentuximab vedotin effective in large-cell lymphoma
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...
Cancer
14 hours ago |
not rated yet |
0
Childhood cancer scars survivors later in life
Scars left behind by childhood cancer treatments are more than skin-deep. The increased risk of disfigurement and persistent hair loss caused by childhood cancer and treatment are associated with emotional distress and reduced ...
Cancer
16 hours ago |
not rated yet |
0
Amino acid consumption associated with how fast cancer cells divide
For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...
Cancer
16 hours ago |
5 / 5 (4) |
1
|
Marked for destruction: Newly developed compound triggers cancer cell death
The BCL-2 protein family plays a large role in determining whether cancer cells survive in response to therapy or undergo a form of cell death known as apoptosis. Cells are pressured toward apoptosis by expression of pro-apoptotic ...
Cancer
20 hours ago |
5 / 5 (1) |
0
Rockefeller scientists pioneer new method to determine mechanisms of drug action
(Medical Xpress) -- Knowing that a drug works is great. Knowing how it works is a luxury. And until now, determining a drugs mechanism of action has been a tedious and difficult process for scientists.
Australia defiant on WTO cigarette challenge
Australia said Friday it would "vigorously defend" itself against complaints about its plan for plain cigarette packaging made by Honduras and Ukraine to the World Trade Organisation.
Chile to cover sex change operations
Chile will soon cover sex change surgeries under its public health plan in order to allow citizens of limited means to "recover their true sexual identity," Health Minister Jaime Manalich said.
Pool access for the disabled sparks controversy
(AP) -- The Obama administration is sidestepping an election-year confrontation with the hotel industry and other pool owners to give them more time to comply with access rules for the disabled.
Better response plans needed for children exposed to domestic violence
(Medical Xpress) -- Each year, millions of children are exposed to domestic violence, a traumatic experience that has been associated with cognitive, behavioral, social and emotional problems in childhood ...
Progestin treatment for polycystic ovarian syndrome may reduce pregnancy chances
(Medical Xpress) -- The hormone progestin, often given as a first step in infertility treatment for polycystic ovary syndrome (PCOS), appears to decrease the odds of conception and of giving birth, according to a study by ...